Approval · Notice of Compliance 727 · 2002
OXYCONTIN: Notice of Compliance 727
Issued December 16, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 727
- Date
- December 16, 2002
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional strength
- Therapeutic class
- Opioid analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXYCONTIN | 02246902 | — |
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 160 MG per TAB